1,7-dimethylxanthine and cannabidiol

1,7-dimethylxanthine has been researched along with cannabidiol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Critchley, D; Tayo, B; Thai, C	1

Trials

1 trial(s) available for 1,7-dimethylxanthine and cannabidiol

Article	Year
A Phase 1 Open-Label, Fixed-Sequence Pharmacokinetic Drug Interaction Trial to Investigate the Effect of Cannabidiol on the CYP1A2 Probe Caffeine in Healthy Subjects. Clinical pharmacology in drug development, 2021, Volume: 10, Issue:11 Topics: Adult; Anticonvulsants; Caffeine; Cannabidiol; Central Nervous System Stimulants; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Drug Interactions; Female; Humans; Male; Theophylline; Young Adult	2021

Article

Year

A Phase 1 Open-Label, Fixed-Sequence Pharmacokinetic Drug Interaction Trial to Investigate the Effect of Cannabidiol on the CYP1A2 Probe Caffeine in Healthy Subjects.

Clinical pharmacology in drug development, 2021, Volume: 10, Issue:11

Topics: Adult; Anticonvulsants; Caffeine; Cannabidiol; Central Nervous System Stimulants; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Drug Interactions; Female; Humans; Male; Theophylline; Young Adult

2021